Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cardiovascular Systems Inc Issues Q3 2013 Guidance; Revenue Guidance Above Analysts' Estimates


Wednesday, 30 Jan 2013 04:00pm EST 

Cardiovascular Systems Inc announced that for the third quarter of 2013, it expects revenue growth of 20% to 25% over the third quarter of 2012, to a range of $25.5 million to $26.5 million and net loss in the range of $(6.6) million to $(7.2) million, or loss per common share ranging from $(0.31) to $(0.34). According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $24.4 million, net income of $(6.7) and EPS of $(0.32) for the third quarter of 2013. 

Company Quote

27.06
-0.73 -2.63%
4:00pm EDT